For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 1-10 results of 13
Gastrointestinal Cancer

Alliance A021502

Official Title: Testing the Addition of the Antibody Atezolizumab to Usual Chemotherapy after Surgery in Patients with Colon Cancer
Study Purpose: To compare any good and bad effects of using the drug atezolizumab along with the usual chemotherapy compared to the usual chemotherapy alone.
Status: Recruiting
Gastrointestinal Cancer

Alliance A021602

Official Title: Testing cabozantinib in patients with advanced pancreatic neuroendocrine and carcinoid tumors after progression on everolimus
Study Purpose: The purpose of this study is to learn if treatment with a drug called cabozantinib to prevent tumor growth is better, the same, or worse than placebo (a pill that contains no active drug).
Status: Recruiting
Gastrointestinal Cancer

Alliance A021806

Official Title: Testing The Use Of The Usual Chemotherapy Before And After Surgery For Removable Pancreatic Cancer
Study Purpose: To determine if receiving chemotherapy before and after surgery will increase the chance of pancreatic cancer staying away.
Status: Recruiting
Gastrointestinal Cancer

Alliance A221805

Official Title: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blinded Placebo-Controlled Phase II to Phase III Study.
Study Purpose: To determine if duloxetine prevent numbness, tingling, and/or pain caused by your cancer treatment with oxaliplatin.
Status: Recruiting
Gastrointestinal Cancer

ECOG-ACRIN EA2165

Official Title: Testing the Addition of the Drug Nivolumab after Surgery for High Risk Anal Cancer
Study Purpose: To find if adding the study drug, nivolumab (also known as OPDIVO), after standard chemotherapy and radiation will prevent the anal cancer from returning.
Status: Recruiting
Gastrointestinal Cancer

ECOG-ACRIN EA2182

Official Title: Study Lower-Dose Chemoradiation for Early-Stage Anal Cancer
Study Purpose: To compare lower-dose chemoradiation therapy to standard-dose chemoradiation therapy and to find out if this approach is better or worse than the usual approach for anal cancer.
Status: Recruiting
Gastrointestinal Cancer

ECOG-ACRIN EA2187

Official Title: Testing the Combination of Pevonedistat With Chemotherapy For Bile Duct Cancer Of The Liver
Study Purpose: To determine if the study drug, pevonedistat alone or pevonedistat in combination with carboplatin and paclitaxel is more efficient in shrinking your cancer.  
Status: Suspended
Gastrointestinal Cancer

Napo Therapeutics NP303-102

Official Title: On Target: A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Crofelemer For The Prophylaxis Of Diarrhea In Adult Patients With Solid Tumors Receiving Targeted-Cancer Therapies With Or Without Standard Chemotherapy Regimens
Study Purpose: To evaluate the safety and efficacy of orally administered crofelemer for prophylaxis of diarrhea in adult patients with solid tumors received targeted cancer therapies with or without standard chemotherapy regimens for their solid tumors.
Status: Recruiting
Gastrointestinal Cancer

Novocure PANOVA-3

Official Title: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields 150kHz) concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreatic adenocarcinoma
Study Purpose: To evaluate the efficacy and safety of TTFields together with standard chemotherapy (gemcitabine and nab-paclitaxel) compared to standard chemotherapy (gemcitabine and nab-paclitaxel) without TTFields. 
Status: Recruiting
Gastrointestinal Cancer

NRG GI004

Official Title: Testing Combination Chemotherapy with or without an Investigational Drug or the Investigational Drug Alone for Metastatic Colon or Rectal Cancer
Study Purpose: To learn if adding the experimental agent atezolizumab (MPDL3280A) to the usual treatment or giving the experimental agent alone is better than the usual treatment alone for metastatic colon or rectal cancer.
Status: Recruiting